ProTransit Nanotherapy

ProTransit Nanotherapy is a pharmaceutical and healthcare company that develops specialized nanotherapies using its patented Pro-NP technology. This proprietary delivery system utilizes biodegradable and biocompatible nanoparticles to transport biomacromolecular therapeutics, such as proteins, enzymes, DNA, and RNA, into targeted cells. By facilitating the sustained release and effective penetration of active ingredients, the technology overcomes historical challenges associated with the delivery of large molecular weight cargo, allowing for versatile applications across dermatology, oncology, and neurology.

The company focuses on both cosmetic and medical applications, leveraging its nanoparticle platform to deliver high-potency antioxidant enzymes to the skin for the prevention of photodamage, including wrinkles and skin cancer. Beyond dermatology, ProTransit has received Department of Defense funding to explore the use of Pro-NP for treating acute spinal cord injuries, aiming to protect the spinal cord and support natural healing mechanisms. By collaborating with academic institutions for clinical research and manufacturing, the company seeks to commercialize its platform for a variety of clinical and preventative healthcare needs.